134 related articles for article (PubMed ID: 7769458)
1. Effect of nicotinic acid on exogenous myocardial glucose utilization.
Stone CK; Holden JE; Stanley W; Perlman SB
J Nucl Med; 1995 Jun; 36(6):996-1002. PubMed ID: 7769458
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
Knuuti MJ; Yki-Järvinen H; Voipio-Pulkki LM; Mäki M; Ruotsalainen U; Härkönen R; Teräs M; Haaparanta M; Bergman J; Hartiala J; Wegelius U; Nuutila P
J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans.
Choi Y; Brunken RC; Hawkins RA; Huang SC; Buxton DB; Hoh CK; Phelps ME; Schelbert HR
Eur J Nucl Med; 1993 Apr; 20(4):308-18. PubMed ID: 8491223
[TBL] [Abstract][Full Text] [Related]
4. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition.
Tamaki N; Yonekura Y; Kawamoto M; Magata Y; Sasayama S; Takahashi N; Nohara R; Kambara H; Kawai C; Konishi J
J Nucl Med; 1991 Nov; 32(11):2152-7. PubMed ID: 1941154
[TBL] [Abstract][Full Text] [Related]
5. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP.
Kudoh T; Tamaki N; Magata Y; Konishi J; Nohara R; Iwasaki A; Ono S; Ohtake Y; Sugihara H; Sugihara H; Kuze K; Tsujimura Y; Miyazaki T
J Nucl Med; 1997 Apr; 38(4):548-53. PubMed ID: 9098200
[TBL] [Abstract][Full Text] [Related]
6. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans.
Gropler RJ; Siegel BA; Lee KJ; Moerlein SM; Perry DJ; Bergmann SR; Geltman EM
J Nucl Med; 1990 Nov; 31(11):1749-56. PubMed ID: 2230987
[TBL] [Abstract][Full Text] [Related]
7. Re-evaluation of myocardial FDG uptake in hyperglycemia.
Kubota K; Kubota R; Yamada S; Tada M; Takahashi T; Iwata R
J Nucl Med; 1996 Oct; 37(10):1713-7. PubMed ID: 8862317
[TBL] [Abstract][Full Text] [Related]
8. The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers.
Berry JJ; Baker JA; Pieper KS; Hanson MW; Hoffman JM; Coleman RE
J Nucl Med; 1991 Aug; 32(8):1518-25. PubMed ID: 1869972
[TBL] [Abstract][Full Text] [Related]
9. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
[TBL] [Abstract][Full Text] [Related]
10. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.
Ohtake T; Yokoyama I; Watanabe T; Momose T; Serezawa T; Nishikawa J; Sasaki Y
J Nucl Med; 1995 Mar; 36(3):456-63. PubMed ID: 7884509
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
[TBL] [Abstract][Full Text] [Related]
12. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
Knuuti MJ; Nuutila P; Ruotsalainen U; Saraste M; Härkönen R; Ahonen A; Teräs M; Haaparanta M; Wegelius U; Haapanen A
J Nucl Med; 1992 Jul; 33(7):1255-62. PubMed ID: 1613561
[TBL] [Abstract][Full Text] [Related]
13. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET.
Knuuti MJ; Nuutila P; Ruotsalainen U; Teräs M; Saraste M; Härkönen R; Ahonen A; Wegelius U; Haapanen A; Bergman J
J Nucl Med; 1993 Dec; 34(12):2068-75. PubMed ID: 8254389
[TBL] [Abstract][Full Text] [Related]
14. Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake.
Ng CK; Soufer R; McNulty PH
J Nucl Med; 1998 Mar; 39(3):379-83. PubMed ID: 9529278
[TBL] [Abstract][Full Text] [Related]
15. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
16. Simplified PET quantitation of myocardial glucose utilization.
Nakagawa K; Namba H; Iyo M; Fukushi K; Irie T; Yamanouchi M; Shikama N; Himi T; Yoshida K; Masuda Y
J Nucl Med; 1995 Nov; 36(11):2094-102. PubMed ID: 7472605
[TBL] [Abstract][Full Text] [Related]
17. Fundamental limitations of [18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake.
Hariharan R; Bray M; Ganim R; Doenst T; Goodwin GW; Taegtmeyer H
Circulation; 1995 May; 91(9):2435-44. PubMed ID: 7729031
[TBL] [Abstract][Full Text] [Related]
18. Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography.
Rechavia E; de Silva R; Kushwaha SS; Rhodes CG; Araujo LI; Jones T; Maseri A; Yacoub MH
J Am Coll Cardiol; 1997 Aug; 30(2):533-8. PubMed ID: 9247529
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of augmented fluorine-18 deoxyglucose uptake in remote normoperfused myocardium in patients with acute coronary syndrome under fasting conditions.
Nakano A; Lee JD; Shimizu H; Yonekura Y; Ueda T
J Nucl Cardiol; 2000; 7(5):454-60. PubMed ID: 11083194
[TBL] [Abstract][Full Text] [Related]
20. Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose.
Bøtker HE; Böttcher M; Schmitz O; Gee A; Hansen SB; Cold GE; Nielsen TT; Gjedde A
J Nucl Cardiol; 1997; 4(2 Pt 1):125-32. PubMed ID: 9115064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
